Early in the Covid pandemic, Adrian Hill, head of Oxford university’s Jenner Institute, needed to find a company to roll out his group’s vaccine. There was a condition: the partner had to charge little in low- and middle-income countries, so that the vaccine wouldn’t be limited to the rich. “If there’s one thing that drives many of us here, the word is inequity,” says Hill, a slight, fast-talking 63-year-old.
在新冠肺炎疫情的早期，牛津大学詹纳研究所所长阿德里安·希尔(Adrian Hill)需要找到一家公司来推广他的团队的疫苗。有一个条件：合作伙伴必须在低收入和中等收入国家收取很少的费用，这样疫苗就不会局限于富人。“如果有一件事驱使我们来到这里，那就是不平等，”希尔说，他今年63岁，身材瘦小，说话语速很快。
您已阅读4%（565字），剩余96%（12996字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。